The impacts of transcatheter occlusion for congenital atrial septal defect on atrial volume, function, and synchronicity in children: a three-dimensional echocardiography study.

Echocardiography

Department of Pediatrics, Pediatric Heart Center, Children's Hospital of Fudan University, Shanghai Medical School, Fudan University, Shanghai, People's Republic of China.

Published: November 2008

Objective: To evaluate the impacts of transcatheter closure for atrial septal defect (ASD) on the atria.

Methods: Thirty-four patients with ASD undergoing transcatheter occlusion were recruited in the study, and 34 patients undergoing surgical operation and 34 healthy children were age-matched as controls. A real time three-dimensional (RT3DE) echocardiography was used to measure the volume, function, and synchronicity of the atria.

Results: There was no difference in the atrial volume and function between the transcatheter occlusion group and healthy control group (P > 0.05). However, the parameters reflecting the atrial asynchrony were larger in the transcatheter occlusion group (P < 0.05). Compared to the surgical repair group, the transcatheter occlusion group had smaller maximum volume of the left atrium (21.0 +/- 5.2 ml/m(2) vs 24.3 +/- 5.8 ml/m(2), P = 0.01), smaller total emptying volume of the left atrium (12.7 +/- 4.3 ml/m(2) vs 15.1 +/- 3.8 ml/m(2), P = 0.014), smaller total emptying volume of the right atrium (13.5 +/- 5.2 ml/m(2) vs 16.1 +/- 4.7 ml/m(2), P = 0.029), and larger atrial systolic asynchrony indices.

Conclusions: An atrial asynchrony is observed in patients with transcatheter closure of ASD, although little negative impacts on the atrial volume and function are demonstrated, which deserves more attention during follow-up of this specific population.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1540-8175.2008.00730.xDOI Listing

Publication Analysis

Top Keywords

+/- ml/m2
24
transcatheter occlusion
20
volume function
16
atrial volume
12
occlusion group
12
impacts transcatheter
8
atrial
8
atrial septal
8
septal defect
8
function synchronicity
8

Similar Publications

Background And Objectives: Cryptogenic strokes account for 20%-25% of all ischemic strokes. Although atrial cardiopathy markers are more prevalent in the cryptogenic embolic stroke of undetermined source (ESUS) subgroup than in the nonembolic stroke subgroup, the utility of individual parameters in predicting cardioembolic sources needs to be studied further. We studied the clinical, imaging, and atrial cardiopathy markers in three ischemic stroke subtypes - large artery atherosclerosis (LAA), cardioembolism (CE), and cryptogenic ESUS - and their role in predicting the source of CE.

View Article and Find Full Text PDF

Aims: Atrial septal defect (ASD) and partial abnormal pulmonary venous connection (PAPVC) are noncyanotic congenital heart defects (CHD) that produce a left-to-right shunt. This single-center retrospective study aimed to assess the hemodynamic impact of isolated ASD, isolated PAPVC, and ASD-associated PAPVC using cardiovascular magnetic resonance (CMR).

Methods And Results: From our CMR registry (2002-2024), 110 patients were included: isolated ASD (n=64), isolated PAPVC (n=18), ASD-associated PAPVC (n=28, mostly sinus venosus septal defects).

View Article and Find Full Text PDF

Aim: To study the factors that influence the occurrence of postoperative atrial fibrillation (POAF) in patients with chronic ischemic heart disease (IHD) after coronary artery bypass grafting (CABG).

Material And Methods: This single-center prospective observational non-randomized study included 152 patients with chronic IHD. Mean age of patients was 64.

View Article and Find Full Text PDF

Aims: Left ventricular (LV) ring-like scar on cardiac magnetic resonance (CMR) has been linked to malignant arrhythmias in patients with non-ischemic cardiomyopathy. This study aimed to perform a comprehensive evaluation of this phenotype and to identify risk factors for life-threatening arrhythmic events (LAEs), a composite of sudden cardiac death (SCD), aborted SCD, and sustained ventricular tachycardia.

Methods And Results: One-hundred-fifteen patients (median age 39 [IQR 28-52], 42% females) were identified at 6 referral centres.

View Article and Find Full Text PDF
Article Synopsis
  • Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic heart condition that leads to thickening of the heart muscle and obstructs blood flow from the left ventricle, making treatment challenging.
  • Mavacamten, a new drug that inhibits cardiac myosin, has shown significant effectiveness in reducing left ventricular outflow tract (LVOT) gradients and improving other heart-related measurements in patients with HOCM, based on a meta-analysis of two randomized controlled trials involving 332 patients.
  • The drug not only demonstrated beneficial effects but also had a favorable safety profile, suggesting it could change how HOCM is managed, although further long-term studies are needed to confirm its effectiveness and safety.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!